Cover Image
市場調查報告書

注射型藥物輸送市場分析:設備各類型 (自行注射設備,傳統設備) 、各劑型,治療用各用途,終端用戶的各用途,各地區及市場區隔預測

Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation, By Therapeutic Use, By End-user Application, By Region, And Segment Forecasts From 2013 to 2024

出版商 Grand View Research, Inc. 商品編碼 370448
出版日期 內容資訊 英文 78 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
注射型藥物輸送市場分析:設備各類型 (自行注射設備,傳統設備) 、各劑型,治療用各用途,終端用戶的各用途,各地區及市場區隔預測 Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation, By Therapeutic Use, By End-user Application, By Region, And Segment Forecasts From 2013 to 2024
出版日期: 2016年08月11日 內容資訊: 英文 78 Pages
簡介

本報告提供全球注射型藥物輸送市場相關調查,彙整市場設備各類型,各劑型,治療用各用途,終端用戶的各用途及地區別別趨勢,今後預測,及加入此市場的主要企業簡介等資料。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測:2013∼2024年
  • 市場趨勢
    • 促進要素
    • 阻礙要素
  • 產業趨勢分析
  • 波特五力分析
  • 波特五力分析模式
  • 企業的市場佔有率分析
  • 優先的主要機會

第4章 各產品類型預測

  • 各產品收益佔有率分析
  • 不同設備
    • 自行注射設備
    • 傳統設備
  • 各劑型
  • 其他

第5章 治療用途預測

  • 治療用途預測別收益佔有率
  • 自體免疫疾病
  • 荷爾蒙疾病
  • 腫瘤
  • 其他

第6章 終端用戶各用途預測

  • 終端用戶各用途收益佔有率
  • 醫院
  • 居家護理設施
  • 其他

第7章 各地區預測

  • 各地區收益分析
  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南美

第8章 企業簡介

  • Pfizer, Inc.
  • Baxter International, Inc.
  • Schott AG
  • Becton, Dickinson and Company
  • ELI Lily and Company
  • Alkermes PLC
  • Terumo Corporation
  • Elcam Medical
  • Unilife Corporation

圖表

目錄
Product Code: 978-1-68048-GVR-8

The global injectable drug delivery market is expected to reach USD 931.1 billion by 2024, according to a new report by Grand View Research, Inc. The increase in number of chronic diseases like diabetes and cancer has fueled the need for injectable drug delivery. Unlike other traditional forms of drug delivery, injectables allow maximum bioavailability of the pharmaceutical drug as it bypasses the first pass metabolism. With substantial growth in technological advancements, the devices being manufactured and marketed are built so as to cater to the specific needs of the patients.

With the advent of self-injection devices, injectable drugs can be self administered without the need of medical assistance. A large number of technology-oriented developments have taken place in the biologics market, which further increases the applicability of these injectable devices in the challenging disease areas. Self-injection devices have allowed patients suffering from diabetes to manage insulin levels with auto-injectors, pen-injectors, and needle-free injectors; thus, the homecare segment has been a large grosser in the end-user application.

The major restraints in this market are injuries and infections caused by needles, ambiguities related to regulatory reimbursements, sterility of the injectable drugs, and the preference of other drug delivery systems that possess less toxicity and are easy to administer. Despite these restraints, the market potential for injectable drug delivery products is tremendous with majority of the key players opting to injectables over other forms of delivery. The injectable drug delivery industry, based on product type is segmented into two sub-types namely self-injection devices and conventional injection devices. Further, on the basis of therapeutic use, the injectable drug delivery industry is segmented into autoimmune disorders, hormonal disorders, oncology, and others.

The injectable drug delivery industry by end-user application is categorized into hospitals, homecare settings, and others including research establishments, diagnostics, and clinical laboratories.

Further key findings from the study suggest:

North America is expected to lead the market for injectable drug delivery devices with the largest number of patients suffering from chronic diseases like diabetes and cancer along with autoimmune disorders. The reason why countries in North America are leading is due to the technological innovations and advanced research in the area that enable them to excel at designing new and improved drug delivery products.

The Asia Pacific market is set to lead exceptionally well owing to the partnerships with other well established global players. This region has also witnessed enormous investments in research and development; thus, accelerating the growth of the injectables market in this region.

The homecare settings has been the most profit garnering segment with a large cohort of patients suffering from chronic diseases and hence the resultant high utility of these devices at a primary level for better control and management of the disease.

Some key market players include Pfizer, Inc., Schott AG, Becton, Dickinson and Company, Baxter International, Inc., and ELI Lilly & Co.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Injectable drug delivery market - Industry Summary and Key Buying Criteria, 2013 - 2024

Chapter 3. Injectable Drug DeliveryIndustry Outlook

  • 3.1. Market segmentation
  • 3.2. Market size and growth prospects, 2013 - 2024
  • 3.3. Injectable drug delivery: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Escalation in demand for self- injection devices
      • 3.3.1.2. Increase in number of chronic diseases
      • 3.3.1.3. Innovative technological progress
      • 3.3.1.4. Development of the biologics market
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Needle stick injuries and infections
      • 3.3.2.2. Preference over other drug delivery systems
      • 3.3.2.3. Sterility of injectables
  • 3.4. Injectable drug delivery market: Industry trend analysis
  • 3.5. Injectable drug delivery market - PESTEL Analysis
  • 3.6. Injectable drug delivery Industry analysis - Porter's Five Forces Model
  • 3.7. Injectable drug delivery: Company Market Share Analysis (%), 2015
  • 3.8. Key opportunities prioritized

Chapter 4. Injectable Drug Delivery Product Type Outlook

  • 4.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Product Outlook, 2016 & 2024
  • 4.2. By Devices
    • 4.2.1. Self-injection devices
      • 4.2.1.1. Self-injection devices market revenue, by region, 2013 to 2024 (USD Million)
    • 4.2.2. Conventional devices
      • 4.2.2.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
  • 4.3. By Formulations
    • 4.3.1. Conventional drug delivery
      • 4.3.1.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
    • 4.3.2. Novel drug delivery
      • 4.3.2.1. Novel drug delivery market revenue, by region, 2013 to 2024 (USD Million)
  • 4.4. Others
    • 4.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)

Chapter 5. Injectable Drug Delivery Therapeutic Use Outlook

  • 5.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Therapeutic Use Outlook, 2016& 2024
  • 5.2. Autoimmune disorders
    • 5.2.1. Autoimmune disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
  • 5.3. Hormonal disorders
    • 5.3.1. Hormonal disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology injectable drug delivery market, by region, 2013 to 2024 (USD Million)
  • 5.5. Others
    • 5.5.1. Others drug injectable drug delivery market, by region, 2013 to 2024 (USD Million)

Chapter 6. Injectable Drug Delivery End-User Application Outlook

  • 6.1. Injectable Drug Delivery Revenue Share (%) Analysis, by End-User Application, 2016& 2024
  • 6.2. Hospital
    • 6.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
  • 6.3. Homecare Settings
    • 6.3.1. Homecare settings market revenue, by region, 2013 to 2024 (USD Million)
  • 6.4. Others
    • 6.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)

Chapter 7. Injectable Drug Delivery Regional Outlook

  • 7.1. Injectable drug delivery Market Share (%) Analysis, by Region, 2013&2024
  • 7.2. North America
    • 7.2.1. U.S.
      • 7.2.1.1. U.S. injectable drug delivery market, by device, 2013 - 2024 (USD Million)
      • 7.2.1.2. U.S injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
      • 7.2.1.3. U.S. injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
      • 7.2.1.4. U.S. injectable drug deliverymarket, by end-user application, 2013 - 2024 (USD Million)
    • 7.2.2. Canada
      • 7.2.2.1. Canada injectable drug delivery market, by device, 2013 - 2024 (USD Million)
      • 7.2.2.2. Canada injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
      • 7.2.2.3. Canada injectable drug delivery market, by therapeutic use,2013 - 2024 (USD Million)
      • 7.2.2.4.Canada injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
  • 7.3. Europe
    • 7.3.1. Germany
      • 7.3.1.1. Germany injectable drug delivery market, by device, 2013 - 2024 (USD Million)
      • 7.3.1.2. Germany injectable drug delivery market by formulation, 2013 - 2024 (USD Million)
      • 7.3.1.3. Germany injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
      • 7.3.1.4. Germany injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK injectable drug delivery market, by device, 2013 - 2024 (USD Million)
      • 7.3.2.2. UK injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
      • 7.3.2.3. UK injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
      • 7.3.2.4. UK injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
  • 7.4. Asia-Pacific
    • 7.4.1. China
      • 7.4.1.1. China injectable drug delivery market, by device, 2013 - 2024 (USD Million)
      • 7.4.1.2. China injectable drug delivery market by formulation, 2013 - 2024 (USD Million)
      • 7.4.1.3. China injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
      • 7.4.1.4. China injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
    • 7.4.2. India
      • 7.4.2.1. India injectable drug delivery market, by device, 2013 - 2024 (USD Million)
      • 7.4.2.2. India injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
      • 7.4.2.3. India injectable drug delivery market, by therapeutic use 2013 - 2024 (USD Million)
      • 7.4.2.4. India injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
  • 7.5. MEA
    • 7.5.1. South Africa
      • 7.5.1.1. South Africa injectable drug delivery market, by device, 2012 - 2024 (USD Million)
      • 7.5.1.2. South Africa injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
      • 7.5.1.3. South Africa injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
      • 7.5.1.4. South Africa injectable drug deliverymarket, by end-user application, 2013 - 2024 (USD Million)
    • 7.5.2. Saudi Arabia
      • 7.5.2.1. Saudi Arabia injectable drug delivery market, by device, 2013 - 2024 (USD Million)
      • 7.5.2.2. Saudi Arabia injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
      • 7.5.2.3. Saudi Arabia injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
      • 7.5.2.4. Saudi Arabia injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Brazil injectable drug delivery market, by device, 2013 - 2024 (USD Million)
      • 7.6.1.2. Brazil injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
      • 7.6.1.3. Brazil injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
      • 7.6.1.4. Brazil injectable drug deliverymarket, by end-user application, 2013 - 2024 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Mexico injectable drug delivery market, by device,2013 - 2024 (USD Million)
      • 7.6.2.2. Mexico injectable drug delivery market, by formulation, 2013 - 2024 (USD Million)
      • 7.6.2.3. Mexico injectable drug delivery market, by therapeutic use, 2013 - 2024 (USD Million)
      • 7.6.2.4. Mexico injectable drug delivery market, by end-user application, 2013 - 2024 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Pfizer, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Strategic Initiatives
  • 8.2. Baxter International, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Strategic Initiatives
  • 8.3. Schott AG
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Strategic Initiatives
  • 8.4. Becton, Dickinson and Company
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Strategic Initiatives
  • 8.5. ELI Lily and Company
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Strategic Initiatives
  • 8.6. Alkermes PLC
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Strategic Initiatives
  • 8.7. Terumo Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Strategic Initiatives
  • 8.8 Elcam Medical
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Strategic Initiatives
  • 8.9 Unilife Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Strategic Initiatives

List of Tables

  • 1. Injectable Drug Delivery - Industry Snapshot & Key Buying Criteria, 2013 - 2024
  • 2. Injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 3. Injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 4. Injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 5. Injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 6. Injectable drug delivery market, by region, 2013 - 2024 (USD Million)
  • 7. Injectable drug delivery - Key Market Driver Analysis
  • 8. Injectable drug delivery - Key Market Restraint Analysis
  • 9. North America Injectable drug delivery market revenue, 2013 - 2024 (USD Million)
  • 10. U.S. injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 11. U.S. injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 12. U.S. injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 13. U.S. injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 14. Canada injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 15. Canada injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 16. Canada injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 17. Canada injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 18. Europe injectable drug delivery market revenue, 2013 - 2024 (USD Million)
  • 19. Germany injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 20. Germany injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 21. Germany injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 22. Germany injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 23. UK injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 24. UK injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 25. UK injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 26. UK injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 27. Asia - Pacific injectable drug delivery market revenue, 2013 - 2024 (USD Million)
  • 28. China injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 29. China injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 30. China injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 31. China injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 32. India injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 33. India injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 34. India injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 35. India injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 36. Latin America injectable drug deliverymarket revenue, 2013 - 2024 (USD Million)
  • 37. Brazil injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 38. Brazil injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 39. Brazil injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 40. Brazil injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 41. Mexico injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 42. Mexico injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 43. Mexico injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 44. Mexico injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 45. MEA injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 46. South Africa injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 47. South Africa injectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 48. South Africa injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 49. South Africa injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)
  • 50. Saudi Arabia injectable drug delivery market revenue, by device, 2013 - 2024 (USD Million)
  • 51. Saudi Arabiainjectable drug delivery market revenue, by formulation, 2013 - 2024 (USD Million)
  • 52. Saudi Arabia injectable drug delivery market revenue, by therapeutic use, 2013 - 2024 (USD Million)
  • 53. Saudi Arabia injectable drug delivery market revenue, by end-user application, 2013 - 2024 (USD Million)

List of Figures

  • 1. Injectable drug delivery: Market segmentation
  • 2. Injectable drug delivery, 2013 - 2024 (USD Million)
  • 3. Injectable drug delivery market: Industry trend analysis
  • 4. Injectable drug delivery market: PESTEL analysis
  • 5. Injectable drug delivery market: Porter's analysis
  • 6. Injectable drug delivery company market share, 2015
  • 7. Key Opportunities Prioritized
  • 8. Injectable drug delivery market revenue shares by device, 2016 & 2024
  • 9. Injectable drug delivery market revenue shares by formulation, 2016 & 2024
  • 10. Injectable drug delivery market revenue shares by therapeutic use, 2016 & 2024
  • 11. Injectable drug delivery market revenue shares by end-user application, 2016 & 2024
  • 12. Injectable drug delivery market revenue shares by region, 2016 & 2024
Back to Top